Cargando…
Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492149/ https://www.ncbi.nlm.nih.gov/pubmed/36634278 http://dx.doi.org/10.1016/j.hemonc.2020.08.002 |
| _version_ | 1783582329617252352 |
|---|---|
| author | Tailor, Imran K. Alshehry, Nawal F. Zaidi, Syed Z. Marei, Mohammed A. Motabi, Ibraheem H. Alfayez, Mansour Altaf, Syed Y. |
| author_facet | Tailor, Imran K. Alshehry, Nawal F. Zaidi, Syed Z. Marei, Mohammed A. Motabi, Ibraheem H. Alfayez, Mansour Altaf, Syed Y. |
| author_sort | Tailor, Imran K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7492149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74921492020-09-16 Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? Tailor, Imran K. Alshehry, Nawal F. Zaidi, Syed Z. Marei, Mohammed A. Motabi, Ibraheem H. Alfayez, Mansour Altaf, Syed Y. Hematol Oncol Stem Cell Ther Letter to Editor King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. 2020-09-16 /pmc/articles/PMC7492149/ /pubmed/36634278 http://dx.doi.org/10.1016/j.hemonc.2020.08.002 Text en © 2020 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editor Tailor, Imran K. Alshehry, Nawal F. Zaidi, Syed Z. Marei, Mohammed A. Motabi, Ibraheem H. Alfayez, Mansour Altaf, Syed Y. Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? |
| title | Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? |
| title_full | Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? |
| title_fullStr | Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? |
| title_full_unstemmed | Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? |
| title_short | Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? |
| title_sort | outcome of myeloma patients with covid-19 on active lenalidomide-based therapy: does lenalidomide protect from severe covid-19? |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492149/ https://www.ncbi.nlm.nih.gov/pubmed/36634278 http://dx.doi.org/10.1016/j.hemonc.2020.08.002 |
| work_keys_str_mv | AT tailorimrank outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 AT alshehrynawalf outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 AT zaidisyedz outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 AT mareimohammeda outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 AT motabiibraheemh outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 AT alfayezmansour outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 AT altafsyedy outcomeofmyelomapatientswithcovid19onactivelenalidomidebasedtherapydoeslenalidomideprotectfromseverecovid19 |